Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07102160 · ClinicalTrials.gov registry record
Cleaner Long-tErm Assessment Registry - Venous Insights and Efficacy With eXtended Tracking
A clinical trial of Deep Vein Thrombosis (DVT) and Venous Embolism, sponsored by Argon Medical Devices.
- Recruiting
- Registry status
- 185
- Enrollment target
- 3
- Study locations
NCT07102160: Recruiting study of Deep Vein Thrombosis (DVT) and Venous Embolism, sponsored by Argon Medical Devices.
NCT07102160 is a study of Deep Vein Thrombosis (DVT) and Venous Embolism that is actively recruiting participants, run by Argon Medical Devices. The registered enrollment target is 185 participants, below the 821-participant average among 3 other Deep Vein Thrombosis (DVT) trials with a reported enrollment target (77% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07102160, a study of Deep Vein Thrombosis (DVT) and Venous Embolism, is actively recruiting participants, sponsored by Argon Medical Devices.
- RECRUITING
- Registry status
- 185 participants
- Enrollment target
- 3
- Study locations
Study Summary
The primary objective of this clinical investigation is to evaluate the safety and effectiveness of the Cleaner Vac® Thrombectomy System for the treatment of thrombus in patients with lower extremity proximal deep vein thrombosis (DVT). This prospective, multi-center, open-label study will assess clinical outcomes, device performance, and procedural success in a single DVT study cohort.
Primary Outcome
≥75% thrombus removal in the target venous segment, assessed by change in Marder Score
Conditions Studied
Interventions
- DEVICE Aspiration thrombectomy system
Study Locations (3)
Florida
- Baycare Health System - Tampa
Kentucky
- St. Elizabeth Healthcare - Edgewood - Edgewood
Texas
- Baylor Scott & White The Heart Hospital - Plano - Plano
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 185 participants |
| Start Date | 2026-02-04 |
| Est. Completion | 2029-06 |
What NCT07102160 shows while recruiting
NCT07102160 is an observational study that tracks outcomes without assigning an intervention. The registered 185 participants enrollment target is mid-sized for trials with a published cap, below the 821-participant average among 3 other Deep Vein Thrombosis (DVT) trials with a reported enrollment target (77% lower).
The record links to 4 conditions, with Deep Vein Thrombosis (DVT) appearing as the primary indexed condition, and to 1 intervention - of which Aspiration thrombectomy system is the first listed.
NCT07102160 reports a single indexed study location in Florida, Kentucky, Texas.
Frequently Asked Questions
What is clinical trial NCT07102160 about?
NCT07102160 is a clinical study titled "Cleaner Long-tErm Assessment Registry - Venous Insights and Efficacy With eXtended Tracking". The primary objective of this clinical investigation is to evaluate the safety and effectiveness of the Cleaner Vac® Thrombectomy System for the treatment of thrombus in patients with lower extremity proximal deep vein thrombosis (DVT). This prospective, multi-center, open-label study will assess cl...
What is the current status of trial NCT07102160?
This trial is currently recruiting. The enrollment target is 185 participants. The study started on 2026-02-04. Estimated completion is 2029-06.
What conditions does trial NCT07102160 study?
This clinical trial studies the following conditions: Deep Vein Thrombosis (DVT), Venous Embolism, Thrombus in the Peripheral Venous Vasculature, Thrombus in the Central and Peripheral Circulatory System, Including Saphenous Vein Grafts.
What interventions are being tested in trial NCT07102160?
The interventions under investigation include: Aspiration thrombectomy system (DEVICE).
Who is sponsoring clinical trial NCT07102160?
This trial is sponsored by Argon Medical Devices, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07102160 being conducted?
This trial has 3 study locations across Florida, Kentucky, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Deep Vein Thrombosis (DVT)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04041154 · 185 participants · NA
Behavioral and Neural Representations of Subjective Effort Cost
- NCT04484272 · 185 participants · NA
A Stress and Pain Self-management m-Health App for Adult Outpatients With Sickle Cell Disease
- NCT05020860 · 185 participants · Phase 2
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
- NCT05793541 · 185 participants · NA
Just-in-time Interventions for Reducing Short-term Suicide Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI